Re: Piper Jaffray analyst
I would add that from what I've read, surgery is not an effective option. T will be the only effective treatment for TED (if approved). I concur with the statement "paradigm-shifting," in the context of HZNP's stock price as well. There seems like an aweful lot of restraint on the part of investors to give HZNP the credit its due for T potential. Somewhere between 6 and 9 months to go (I think it will be early 2nd quarter based on the expectation that filing will be done mid-year).